Tower Research Capital LLC (Trc) Clovis Oncology, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.05 - $1.3 $501 - $13,037	-10,029 Reduced 93.83%	660 $0
Q3 2022 Nov 10, 2022	SELL	$1.05 - $2.85 $8,650 - $23,481	-8,239 Reduced 43.53%	10,689 $13,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $61,578 - $289,319	-97,743 Reduced 83.78%	18,928 $35,000
Q1 2022 May 12, 2022	BUY	$1.43 - $3.14 $94,979 - $208,555	66,419 Added 132.17%	116,671 $236,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $22,482 - $39,636	-8,327 Reduced 14.21%	50,252 $136,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $173,171 - $247,387	42,653 Added 267.82%	58,579 $262,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $54,416 - $76,422	10,840 Added 213.13%	15,926 $92,000
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $21,337 - $45,868	-4,436 Reduced 46.59%	5,086 $36,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $409,774 - $635,993	-99,219 Reduced 91.24%	9,522 $46,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $289,932 - $464,373	60,152 Added 123.8%	108,741 $634,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $276,471 - $470,827	48,589 New	48,589 $328,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $836 - $2,442	-222 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$3.0 - $16.43 $897 - $4,912	-299 Reduced 57.39%	222 $2,000
Q3 2019 Nov 05, 2019	BUY	$3.93 - $15.35 $1,509 - $5,894	384 Added 280.29%	521 $2,000
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $6,148 - $12,321	-480 Reduced 77.8%	137 $2,000
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $9,130 - $15,654	517 Added 517.0%	617 $15,000
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $1,163 - $3,267	100 New	100 $2,000
Q2 2018 Aug 15, 2018	SELL	$42.06 - $62.4 $2,018 - $2,995	-48 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $29,219 - $39,480	-583 Reduced 92.39%	48 $3,000
Q4 2017 Feb 09, 2018	SELL	$57.69 - $84.58 $136,840 - $200,623	-2,372 Reduced 78.99%	631 $43,000
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $201,711 - $254,684	3,003	3,003 $248,000

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account